glp 1 and flu shot Semaglutide: Safety, Timing, and What to Know Navigating Cold & Flu Season

(HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agonist designed for once-monthly subcutaneous dosing in obesity treatment.

Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trumps most-favored nation pricing plan

These medications often reduce appetite, making it important to focus on nutrient-dense, high-protein meals that support satiety and muscle maintenance

Brandclub earns you cash rewards when you engage with your favorite brands while shopping online or in-store.

Just as GenAI is looking like a general-purpose technology that can help businesses across the economy, GLP-1s are looking like a general-purpose wonder drug.